HSN Code 29419030: Other | Ciprofloxacine And Its Salts0

HSN Code 29419030 represents Other | Ciprofloxacine And Its Salts0 under GST classification. This code helps businesses identify Other | Ciprofloxacine And Its Salts0 correctly for billing, taxation, and trade. With HSN Code 29419030, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import or export of Other | Ciprofloxacine And Its Salts0.

Live Demo Available Today

Experience the power of Expert Accounting

Join our guided walkthrough to see how BUSY can transform your business operations.

Trusted by 6,00,000+ Users
4.6 Google Rating
+91
expand_more

* No credit card required

Description of Goods for HSN Code 29419030

HSN Code 29419030 relates to the following description.

Description of Goods

Other : Ciprofloxacine and its salts

Chapter

29 - Organic chemicals

Sub Chapter

2941 - Antibiotics

CGST

9%

SGST

9%

IGST

18%

CESS

0%

What does HSN Code 29419030 not include?

Other | Ciprofloxacine And Its Salts0 does not include products with the following descriptions.

Penicillins and their derivative with a penicillanic acid structure; salts thereof : Penicillins and its salts ( e.g. procaine penicillin, penicillin G-potassium)

Penicillins and their derivative with a penicillanic acid structure; salts thereof : Ampicilline and its salts

Penicillins and their derivative with a penicillanic acid structure; salts thereof : Amoxycilline and its salts

Penicillins and their derivative with a penicillanic acid structure; salts thereof : Cioxacilline and its salts

Penicillins and their derivative with a penicillanic acid structure; salts thereof : 6-APA

Penicillins and their derivative with a penicillanic acid structure; salts thereof : Other

Penicillins and their derivative with a penicillanic acid structure; salts thereof :Streptomycins and their derivatives; salts thereof : Streptomycin

Penicillins and their derivative with a penicillanic acid structure; salts thereof : Other

Tetracyclines and their derivatives, salts thereof : Doxycycline and its salts

Tetracyclines and their derivatives, salts thereof :Tetracycline/oxytetra-cycline and their salts

India’s Trade Performance — HSN Code 29419030 in FY 2024-25

TradeStat EIDB — Ministry of Commerce & Industry FY 2018-19–FY 2024-25 Values in ₹ Crore

India’s Exports

FY 2024-25

₹211 Cr

+10.72% vs FY 2023-24

0.0057% of India’s total exports

India’s Imports

FY 2024-25

₹80 Cr

+16.42% vs FY 2023-24

0.0013% of India’s total imports

Trade Balance

FY 2024-25

₹130 Cr

Trade Surplus

Surplus rank #1419 of 12657 HSN codes

% of Sub-Chapter 2941

FY 2024-25

2.36%

Share of Sub-Chapter 2941’s total exports in FY 2024-25

Import side: 0.48% of Sub-Chapter 2941’s imports

Rank Within Sub-Chapter 2941

FY 2024-25

#6 of 24

Position by export value among HSN codes in Sub-Chapter 2941

Import-side rank: #15 of 24

At a glance

3.06%

Export CAGR

FY 2018-19 → FY 2024-25 · 7 fiscal years

#1783

National Export Rank

of 12657 HSN codes by export value, FY 2024-25

+14.78%

Peak Growth Year

FY 2022-23 · strongest single-year move

2.36%

Contribution to Sub-Ch. 2941

Share of Sub-Chapter 2941 exports in FY 2024-25

India Export-Import Trade Statistics for HSN Code 29419030

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

FY 2018-19 Exp. Rank #1440

Balance

+128.77

Exports

175.83 ₹ Cr

0.0077% share

YoY

2.86% of Sub-Ch. 2941

Imports

47.06 ₹ Cr

0.0013% share

YoY

0.46% of Sub-Ch. 2941

FY 2019-20 Exp. Rank #1463

Balance

+64.46

Exports

170.53 ₹ Cr

0.0077% share

−3.01% YoY

2.85% of Sub-Ch. 2941

Imports

106.07 ₹ Cr

0.0032% share

+125.39% YoY

1.13% of Sub-Ch. 2941

FY 2020-21 Exp. Rank #1406

Balance

+121.26

Exports

192.72 ₹ Cr

0.0090% share

+13.01% YoY

2.80% of Sub-Ch. 2941

Imports

71.46 ₹ Cr

0.0025% share

−32.63% YoY

0.65% of Sub-Ch. 2941

FY 2021-22 Exp. Rank #1572

Balance

+139.54

Exports

217.60 ₹ Cr

0.0069% share

+12.91% YoY

3.72% of Sub-Ch. 2941

Imports

78.06 ₹ Cr

0.0017% share

+9.24% YoY

0.63% of Sub-Ch. 2941

FY 2022-23 Exp. Rank #1499

Balance

+126.80

Exports

249.77 ₹ Cr

0.0069% share

+14.78% YoY

3.28% of Sub-Ch. 2941

Imports

122.97 ₹ Cr

0.0021% share

+57.53% YoY

0.93% of Sub-Ch. 2941

FY 2023-24 Exp. Rank #1828

Balance

+121.23

Exports

190.23 ₹ Cr

0.0053% share

−23.84% YoY

2.19% of Sub-Ch. 2941

Imports

69.00 ₹ Cr

0.0012% share

−43.89% YoY

0.42% of Sub-Ch. 2941

FY 2024-25 Exp. Rank #1783

Balance

+130.30

Exports

210.63 ₹ Cr

0.0057% share

+10.72% YoY

2.36% of Sub-Ch. 2941

Imports

80.33 ₹ Cr

0.0013% share

+16.42% YoY

0.48% of Sub-Ch. 2941

CAGR · 7-Year

Exports

3.06% /yr

Imports

9.32% /yr

Consistently Surplus
Sub-Chapter 2941 total

reference, FY 2024-25

Export

₹8,911.10 Cr

Import

₹16,863.86 Cr

Trade Balance

−7,952.76

Peak export growth year Latest available data Not available YoY = change vs previous FY

Key Trade Insights: HSN Code 29419030 Export-Import Analysis

Consistent Export Growth: 3.06% CAGR Over 7 Years

India's exports under HSN Code 29419030 have grown at a compound annual rate of 3.06% over 7 fiscal years, rising from ₹175.83 Crore in FY 2018-19 to ₹210.63 Crore in FY 2024-25.

HSN Code 29419030 Ranked #1783 Among All 12657 HSN codes by Export Value

In FY 2024-25, HSN Code 29419030 ranks #1783 out of 12657 HSN codes by total export value. Within Sub-Chapter 2941, it ranks #6 of 24. By trade surplus, it ranks #1419 of 12657.

FY 2022-23 Was the Strongest Growth Year for HSN Code 29419030 Exports

The strongest single-year export movement for HSN Code 29419030 was recorded in FY 2022-23, when exports surged by 14.78% over the prior year.

India Maintains a Trade Surplus of ₹130.30 Crore in HSN Code 29419030 Goods

In FY 2024-25, India's exports of ₹210.63 Cr exceeded imports of ₹80.33 Cr, resulting in a trade surplus of ₹130.30 Crore — ranking #1419 of 12657 by surplus magnitude.

Import Growth of 9.32% CAGR Signals Stable Import Dependency for Other | Ciprofloxacine And Its Salts0

India's imports under HSN Code 29419030 have grown at 9.32% CAGR, reaching ₹80.33 Crore in FY 2024-25.

HSN Code 29419030 Contributes 2.36% of Sub-Chapter 2941 Exports — Ranked #6

Among the 24 HSN codes under Sub-Chapter 2941, HSN Code 29419030 ranks #6 by export value — accounting for 2.36% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.48% share (rank #15).

Stop worrying about HSN & TAX compliance

BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.

Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
+91
expand_more

* No credit card required

Frequently Asked Questions

Clear answers to common queries about HSN Code 29419030 and GST compliance.

What products are classified under HSN 29419030 ?

It includes Other | Ciprofloxacine And Its Salts0

Can we claim ITC on inputs used to trade Other / Ciprofloxacine And Its Salts0?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

Does packaging or labelling change the GST for Other / Ciprofloxacine And Its Salts0?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

Any common misclassification issue with Other / Ciprofloxacine And Its Salts0?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

How should mixed supplies be billed when Other / Ciprofloxacine And Its Salts0 is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Other / Ciprofloxacine And Its Salts0; Nil for exempt items if applicable).

How much GST applies to Other / Ciprofloxacine And Its Salts0?

Under HSN 29419030, Other / Ciprofloxacine And Its Salts0 attracts Varies when sold in taxable form. Describe the exact form on the invoice.

Important Disclaimer

The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.